White, odorless powder.
In pyrotechnics, manufacturing iridescent glass, refining sugar.
Registry Numbers and Inventories.
Swiss Giftliste 1
Japan ENCS (MITI)
Melting point, °C
Boiling point, °C
2647 (1 torr)
Solubility in water
Heat of fusion
Hazards and Protection.
Store in a tightly sealed container in a cool, dry location. Keep tightly sealed when not in use.
All chemicals should be considered hazardous. Avoid direct physical contact. Use appropriate, approved safety equipment. Untrained individuals should not handle this chemical or its container. Handling should occur in a chemical fume hood.
Chemical resistent gloves, protective clothing and chemical goggles.
NIOSH/NSHA approved respirator.
Evacuate and ventilate area. Sweep up and place in a bag. Hold for proper disposal. Wear protective clothing.
Stable at normal temperatures and pressures.
Extinguish fire using media most appropriate for surrounding conditions. Wear NIOSH/MSHA approved SCBA and full protective equipment.
Harmful if ingested.
Harmful if inhaled. May cause lung irritation.
May cause irritation.
May cause irritation.
The possible benefit of early removal of some ingested material by cautious gastric lavage must be weighed against potential complications of bleeding or perforation. Activated charcoal activated charcoal binds most toxic agents and can decrease their systemic absorption if administered soon after ingestion. Activated charcoal: administer charcoal as a slurry (240 ml water/30 g charcoal). Usual dose: 25 to 100 g in adults/adolescents.
Move patient to fresh air. Monitor for respiratory distress. If cough or difficulty breathing develops, evaluate for respiratory tract irritation, bronchitis, or pneumonitis. Administer oxygen and assist ventilation as required. Treat bronchospasm with beta2 agonist and corticosteroid aerosols.
Remove contaminated clothing then flush area with water for at least 15 minutes. Wash clothing before reuse.
Irrigate exposed eyes with copious amounts of tepid water for at least 15 minutes. If irritation, pain, swelling, lacrimation, or photophobia persist, the patient should be seen in a health care facility.